🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Sensitive Skin

Dietary Intervention on Atopy NCT06547372NA1 site📍 Singapore National University of Singapore · Tests: Dietary Intervention on Atopy Dupixent and Narrowband UVB for Atopic Dermatitis NCT05285839Phase 41 site📍 East Windsor Psoriasis Treatment Center of Central New Jersey · Tests: Dupixent Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients NCT07114627n/a1 site📍 Rotterdam Erasmus Medical Center · Tests: Blood sampling for pharmacokinetics Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device 047 TD Dermatitis Cream in Adults and Children With Atopic and Contact Dermatitis Symptoms Confirmed by Clinical Parameters NCT07056569NA3 sites📍 Milan📍 Verona📍 Voghera Biokosmes Srl · Tests: 047_TD Dermatitis cream twice a day for 28 days A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD) NCT07239947Phase 110 sites📍 Hefei📍 Wuhu📍 Beijing Bambusa Therapeutics · Tests: BBT001, Placebo Characteristics and Management of Patients With Severe Chronic Spontaneous and/or Inducible Urticaria Refractory to Optimized Omalizumab Treatment: A French Multicenter Observational Study. NCT07833696n/a1 site📍 Besançon Centre Hospitalier Universitaire de Besancon · Tests: drug effect Study of Ravulizumab in Pediatric Participants With Primary IgAN NCT07024563Phase 315 sites📍 Palo Alto📍 Aurora📍 Beijing Alexion Pharmaceuticals, Inc. · Tests: Ravulizumab A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis NCT07235384Phase 112 sites📍 Woolloongabba📍 Carlton📍 Beijing Zai Lab (Shanghai) Co., Ltd. · Tests: ZL-1503, Placebo, ZL-1503, Placebo Molecular Signatures in Inflammatory Skin Disease NCT03358693n/a1 site📍 Kiel Prof. Dr. Stephan Weidinger · Tests: Anti-TNF, Anti-IL12/23, Anti-IL17, Dupilumab, Anti-IL23 A Study to Observe How Pediatric Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions Respond to Dupilumab Treatment NCT06192563n/a9 sites📍 Bologna📍 Brescia📍 Florence Sanofi · Tests: Dupilumab Chemotherapy Omission in ER+/HER2- Breast Cancer With 1-3 Positive Lymph Nodes Receiving Extended Adjuvant Abemaciclib NCT06341621Phase 31 site📍 Shanghai Fudan University · Tests: 3-year abemaciclib without chemo, treatment of physician's choice A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Atopic Dermatitis NCT07015762Phase 11 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: IBI3002, Placebo Topical Treatment for Atopic Dermatitis NCT06244212NA1 site📍 Winston-Salem Wake Forest University Health Sciences · Tests: Demonstration of applying triamcinolone cream, Mobile App Use, Standard of Care Sodium in the Skin and Atopic Dermatitis NCT06998446n/a2 sites📍 San Francisco📍 San Francisco University of California, San Francisco Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis NCT07316465NA1 site📍 Jette Universitair Ziekenhuis Brussel · Tests: Development of atopic dermatitis with/without IgE autoantibodies Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing NCT06413212n/a1 site📍 Wuhan Liu Huang · Tests: Patient-derived tumor-like cell clusters (PTC) drug sensitivity testing. Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks NCT07014007NA1 site📍 Quatre Bornes Pierre Fabre Dermo Cosmetique · Tests: RV4421B- EV0407 A Study of Takhzyro in Teenagers and Adults With Hereditary Angioedema (HAE) in South Korea NCT07445087n/a3 sites📍 Suwon📍 Seoul📍 Seoul Takeda · Tests: No intervention Comparison of Skin Prick Testing, Extract-specific IgE Antibody Testing and Component Resolved Diagnosis in Diagnosing of Legume Allergy NCT06923878n/a1 site📍 Pilsen University Hospital Pilsen Global Healthcare Study on Atopic Dermatitis NCT07659756n/a1 site📍 Zurich Julia Tatjana Maul A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis NCT07598383Phase 21 site📍 Hangzhou Jiangsu vcare pharmaceutical technology co., LTD · Tests: VC005 group, VC005 Placebo group BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Dermatitis NCT03549416n/a14 sites📍 Nijmegen📍 Zwolle📍 Leeuwarden UMC Utrecht Spanish Academy of Dermatology and Venereology Registry of Atopic Dermatitis Therapy NCT05674695n/a9 sites📍 Badalona📍 Alicante📍 Barcelona Fundación Academia Española de Dermatología · Tests: Ciclosporin Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases NCT06599411n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Sampling, Sampling Trial of JYB1904 in Chronic Spontaneous Urticaria. NCT06509334Phase 21 site📍 Beijing Jemincare · Tests: JYB1904, JYB1904, Omalizumab Reflectance Confocal Microscopy Evaluation of Skin Structure of Patients With Atopic Dermatitis Under Nemolizumab NCT07730788n/a1 site📍 Romans-sur-Isère Hôpitaux Drôme Nord Angioedema Biomarker Research Study NCT06210698n/a1 site📍 Wheaton Foundation For Rare Disease Research · Tests: Venipuncture FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients NCT06564389Phase 15 sites📍 Anaheim📍 San Diego📍 Miami Pfizer · Tests: PF-07832837, Placebo SHAPE Trial: Skin Health and Allergy Prevention Exposure NCT07489040NA1 site📍 Hamilton McMaster University · Tests: Multi-component environmental package, standard of care Microbiome in Atopic Dermatitis Under Systemic Therapy NCT05099315n/a1 site📍 Berlin Charite University, Berlin, Germany · Tests: not applicable, observational study
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy